Emerging in the landscape of excess body fat therapy, retatrutide represents a different method. Beyond many available medications, retatrutide works as a dual agonist, simultaneously affecting both GLP-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) sensors. This simultaneous stimulation fosters multiple advantageous effe